How much revenue did Nevro generate this year?
Nevro has achieved a revenue of 414.03 M USD this year.
Nevro Revenue 2025
Nevro Revenue
414.03 M USD
Ticker
NVRO
ISIN
US64157F1030
WKN
A12EPL
In 2025, Nevro's sales reached 414.03 M USD, a 0.5% difference from the 411.99 M USD sales recorded in the previous year.
The Nevro Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2030e | 540.29 | 53,69 |
| 2029e | 518.52 | 55,94 |
| 2028e | 493.92 | 58,73 |
| 2027e | 459.18 | 63,17 |
| 2026e | 431.53 | 67,22 |
| 2025e | 414.03 | 70,06 |
| 2024e | 411.99 | 70,40 |
| 2023 | 425.17 | 68,22 |
| 2022 | 406.4 | 68,01 |
| 2021 | 386.9 | 68,75 |
| 2020 | 362 | 69,03 |
| 2019 | 390.3 | 68,77 |
| 2018 | 387.3 | 70,57 |
| 2017 | 326.7 | 69,70 |
| 2016 | 228.5 | 67,00 |
| 2015 | 69.6 | 59,63 |
| 2014 | 32.6 | 65,34 |
| 2013 | 23.5 | 59,57 |
| 2012 | 18.2 | 58,24 |
Nevro Revenue, EBIT, Net Income US64157F1030 · A12EPL
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Nevro, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Nevro from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Nevro’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Nevro. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Nevro’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Nevro’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Nevro’s growth potential.
Nevro Revenue, EBIT and net profit per share
| Date | Nevro Revenue | Nevro EBIT | Nevro Net Income |
|---|---|---|---|
| 2030e | 540.29 M undefined | 0 undefined | -27.9 M undefined |
| 2029e | 518.52 M undefined | -35.34 M undefined | -38.6 M undefined |
| 2028e | 493.92 M undefined | -48.93 M undefined | -54.27 M undefined |
| 2027e | 459.18 M undefined | -60.08 M undefined | -70.32 M undefined |
| 2026e | 431.53 M undefined | -71.89 M undefined | -80.99 M undefined |
| 2025e | 414.03 M undefined | -86.22 M undefined | -94.55 M undefined |
| 2024e | 411.99 M undefined | -101.82 M undefined | -92.85 M undefined |
| 2023 | 425.17 M undefined | -99.31 M undefined | -92.21 M undefined |
| 2022 | 406.4 M undefined | -98.8 M undefined | 3 M undefined |
| 2021 | 386.9 M undefined | -90.9 M undefined | -131.4 M undefined |
| 2020 | 362 M undefined | -62.9 M undefined | -83.1 M undefined |
| 2019 | 390.3 M undefined | -96.5 M undefined | -103.7 M undefined |
| 2018 | 387.3 M undefined | -41.7 M undefined | -49.2 M undefined |
| 2017 | 326.7 M undefined | -29.6 M undefined | -36.7 M undefined |
| 2016 | 228.5 M undefined | -23 M undefined | -31.8 M undefined |
| 2015 | 69.6 M undefined | -62.4 M undefined | -67.4 M undefined |
| 2014 | 32.6 M undefined | -28.3 M undefined | -30.8 M undefined |
| 2013 | 23.5 M undefined | -25.2 M undefined | -26.2 M undefined |
| 2012 | 18.2 M undefined | -19.1 M undefined | -19.1 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2012 | 18.2 M USD | -19.1 M USD | -19.1 M USD |
| 2013 | 23.5 M USD | -25.2 M USD | -26.2 M USD |
| 2014 | 32.6 M USD | -28.3 M USD | -30.8 M USD |
| 2015 | 69.6 M USD | -62.4 M USD | -67.4 M USD |
| 2016 | 228.5 M USD | -23 M USD | -31.8 M USD |
| 2017 | 326.7 M USD | -29.6 M USD | -36.7 M USD |
| 2018 | 387.3 M USD | -41.7 M USD | -49.2 M USD |
| 2019 | 390.3 M USD | -96.5 M USD | -103.7 M USD |
| 2020 | 362 M USD | -62.9 M USD | -83.1 M USD |
| 2021 | 386.9 M USD | -90.9 M USD | -131.4 M USD |
| 2022 | 406.4 M USD | -98.8 M USD | 3 M USD |
| 2023 | 425.17 M USD | -99.31 M USD | -92.21 M USD |
| 2024e | 411.99 M USD | -101.82 M USD | -92.85 M USD |
| 2025e | 414.03 M USD | -86.22 M USD | -94.55 M USD |
| 2026e | 431.53 M USD | -71.89 M USD | -80.99 M USD |
| 2027e | 459.18 M USD | -60.08 M USD | -70.32 M USD |
| 2028e | 493.92 M USD | -48.93 M USD | -54.27 M USD |
| 2029e | 518.52 M USD | -35.34 M USD | -38.6 M USD |
| 2030e | 540.29 M USD | 0 USD | -27.9 M USD |
Nevro stock margins US64157F1030 · A12EPL
The Nevro margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Nevro. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Nevro.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Nevro's sales revenue. A higher gross margin percentage indicates that the Nevro retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Nevro's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Nevro's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Nevro's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Nevro. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Nevro's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Nevro Margin History
| Nevro Gross margin | Nevro Profit margin | Nevro EBIT margin | Nevro Profit margin |
|---|---|---|---|
| 2030e | 68.22 % | 0 % | -5.16 % |
| 2029e | 68.22 % | -6.82 % | -7.44 % |
| 2028e | 68.22 % | -9.91 % | -10.99 % |
| 2027e | 68.22 % | -13.08 % | -15.32 % |
| 2026e | 68.22 % | -16.66 % | -18.77 % |
| 2025e | 68.22 % | -20.83 % | -22.84 % |
| 2024e | 68.22 % | -24.71 % | -22.54 % |
| 2023 | 68.22 % | -23.36 % | -21.69 % |
| 2022 | 68.01 % | -24.31 % | 0.74 % |
| 2021 | 68.75 % | -23.49 % | -33.96 % |
| 2020 | 69.03 % | -17.38 % | -22.96 % |
| 2019 | 68.77 % | -24.72 % | -26.57 % |
| 2018 | 70.57 % | -10.77 % | -12.7 % |
| 2017 | 69.7 % | -9.06 % | -11.23 % |
| 2016 | 67 % | -10.07 % | -13.92 % |
| 2015 | 59.63 % | -89.66 % | -96.84 % |
| 2014 | 65.34 % | -86.81 % | -94.48 % |
| 2013 | 59.57 % | -107.23 % | -111.49 % |
| 2012 | 58.24 % | -104.95 % | -104.95 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2012 | 58.24 % | -104.95 % | -104.95 % |
| 2013 | 59.57 % | -107.23 % | -111.49 % |
| 2014 | 65.34 % | -86.81 % | -94.48 % |
| 2015 | 59.63 % | -89.66 % | -96.84 % |
| 2016 | 67 % | -10.07 % | -13.92 % |
| 2017 | 69.7 % | -9.06 % | -11.23 % |
| 2018 | 70.57 % | -10.77 % | -12.7 % |
| 2019 | 68.77 % | -24.72 % | -26.57 % |
| 2020 | 69.03 % | -17.38 % | -22.96 % |
| 2021 | 68.75 % | -23.49 % | -33.96 % |
| 2022 | 68.01 % | -24.31 % | 0.74 % |
| 2023 | 68.22 % | -23.36 % | -21.69 % |
| 2024e | 68.22 % | -24.71 % | -22.54 % |
| 2025e | 68.22 % | -20.83 % | -22.84 % |
| 2026e | 68.22 % | -16.66 % | -18.77 % |
| 2027e | 68.22 % | -13.08 % | -15.32 % |
| 2028e | 68.22 % | -9.91 % | -10.99 % |
| 2029e | 68.22 % | -6.82 % | -7.44 % |
| 2030e | 68.22 % | 0 % | -5.16 % |
Nevro Aktienanalyse
What does Nevro do?
Nevro Corp is a global leader in innovative medical products and therapy systems. The company was founded in 2006 and is headquartered in Redwood City, California. Nevro Corp is a pioneer in the development of novel implantable medical technologies and has brought a variety of products to the market since its founding, enabling revolutionary advances in pain therapy. Nevro Corp's business model is based on the production, marketing, and sale of implantable neuromodulation devices that can reduce or even eliminate chronic pain in patients. These devices are able to send electrical signals to individual nerve fibers to target and treat pain in specific areas of the body. With this innovative technology, Nevro Corp has revolutionized the pain therapy market and filled a niche that conventional treatment methods could not address. Nevro Corp has various divisions and branches worldwide. An important area of the company is research and development, where new and innovative pain therapy technologies are constantly being developed. Another division is marketing, where the company's products are sold to medical specialists, hospitals, and clinics worldwide. In addition, Nevro Corp also offers training and education to inform medical professionals about the company and its products. The products offered by Nevro Corp include implantable neuromodulation systems such as the Senza system and the HF10 system. The Senza system is a spinal cord stimulator that is controlled via a remote and sends electrical impulses to the spinal cord to relieve pain in the arms, legs, and back. The HF10 system works with high-frequency technology and was developed to treat chronic pain in the lower back. In addition to these products, Nevro Corp has also introduced a range of accessories and enhancements to facilitate the operation and maintenance of the implantable devices. These include, for example, wireless chargers or a special remote control that allows patients to individually adjust their therapy. In summary, Nevro Corp is an innovative and successful provider of medical products and therapy systems specializing in pain therapy. With sophisticated technology, state-of-the-art research and development, and a dedicated workforce, the company has made a significant contribution to improving the quality of life for millions of patients worldwide and will continue to develop innovative and effective therapies in the future. Nevro ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Nevro's Sales Figures
The sales figures of Nevro originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Nevro’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Nevro's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Nevro’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Nevro stock
How much was the turnover of the company Nevro compared to the previous year?
The revenue of Nevro has increased by 0.5% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Nevro?
The revenue of Nevro is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Nevro measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Nevro so important for investors?
The revenue of Nevro is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Nevro pay?
Over the past 12 months, Nevro paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nevro is expected to pay a dividend of 0 USD.
What is the dividend yield of Nevro?
The current dividend yield of Nevro is .
When does Nevro pay dividends?
Nevro pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nevro?
Nevro paid dividends every year for the past 0 years.
What is the dividend of Nevro?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nevro located?
Nevro is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nevro kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nevro from 1/28/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/28/2025.
When did Nevro pay the last dividend?
The last dividend was paid out on 1/28/2025.
What was the dividend of Nevro in the year 2024?
In the year 2024, Nevro distributed 0 USD as dividends.
In which currency does Nevro pay out the dividend?
The dividends of Nevro are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Nevro stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Nevro
Our stock analysis for Nevro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nevro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
